The Dip.io app is currently restricted to multiple sclerosis (MS) patients who are part of a trial programme managed by the Neuro Response team.
The Dip.io app is part of a simple, home-based urinalysis test that screens for a wide range of clinical conditions. Using a standard urine dipstick and a designated kit, the app analyses urine and securely transmits the results to your healthcare provider.